On November 5, 2026, AMN Healthcare Services, Inc. reported its results for the fiscal quarter ended September 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
|
AMN Healthcare Services Inc is a healthcare staffing and workforce solutions provider serving the United States. The company offers temporary and permanent placement for nurses, physicians, allied health professionals, and healthcare executives. Its service portfolio includes managed services programs, vendor management systems, medical language interpretation, recruitment process outsourcing, and revenue cycle solutions. AMN Healthcare operates technology platforms such as WorkWise, ShiftWise Flex, and AMN Passport to manage scheduling, credentialing, and clinician engagement. The company also provides event management systems for labor disruption staffing and locum tenens services. Clients include healthcare facilities of various sizes across the nation. The firm utilizes a network of highly qualified healthcare professionals to address workforce challenges and optimize patient care delivery. Summarised from the company's own disclosures, fiscal year ended Feb 2026 |
Industry Staffing & Employment Services | Homepage amnhealthcare.com |
| Sector Industrials | IR page ir.amnhealthcare.com | |
|
Tags
healthcare staffing, nurse staffing, physician staffing, allied health staffing, locum tenens, managed services programs, vendor management systems, recruitment process outsourcing, language interpretation, revenue cycle solutions, workforce optimization, healthcare technology, WorkWise, ShiftWise Flex, AMN Passport, Staff Care, Merritt Hawkins, AMN Healthcare Revenue Cycle Solutions, AMN Healthcare Language Services, Event Management System
|
Press page ir.amnhealthcare.com/press-releases |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 1.38B |
| Market cap (USD) | $ 1.38B |
| P/E | 13.00 |
| PEG | — |
| P/BV | 1.78 |
| P/S | 0.39 |
| P/OCF | 3.83 |
| P/FCF | 4.22 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -14.2% |
| ROI | -6.8% |
| ROIC | -3.0% |
| Profit margin | -3.5% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | 119.5% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 15 |
| Quality score | -33.3% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.73B | 2.984B | 3.789B | 5.243B | 3.984B | 2.394B | 2.222B | 2.136B | 1.988B | 1.902B | 1.463B | 1.036B | 1.012B | 953.951M | 887.466M | 669.912M | 759.79M | 1.217B | 1.164B | 1.082B | 705.843M | 629.016M | 714.209M | 775.683M | 517.794M | 230.766M |
| Net profit | -95.702M | -146.979M | 210.679M | 444.05M | 327.388M | 70.665M | 113.988M | 141.741M | 132.558M | 105.838M | 81.891M | 33.217M | 32.933M | 17.136M | -26.265M | -51.991M | -122.177M | 34.357M | 36.532M | 35.091M | 22.234M | 17.346M | 37.792M | 52.356M | -4.386M | -5.198M |
| Free cash flow | 233.828M | 239.527M | 268.478M | 577.902M | 251.783M | 219.124M | 189.644M | 191.787M | 88.733M | 109.895M | 29.303M | 8.544M | 49.59M | 55.04M | 14.664M | 3.921M | 94.943M | 54.939M | 70.485M | 44.824M | 40.272M | 33.977M | 52.132M | 52.525M | -2.818M | -3.936M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 15.76 | 23.92 | 74.88 | 102.82 | 122.33 | 68.25 | 62.31 | 56.66 | 49.25 | 38.45 | 31.05 | 19.6 | 14.7 | 11.54 | 4.48 | 6.24 | — | — | — | — | — | — | — | — | — | — |
| Price performance 12m | -0.34 | -0.68 | -0.27 | -0.16 | 0.79 | 0.1 | 0.1 | 0.15 | 0.28 | 0.24 | 0.58 | 0.33 | 0.27 | 1.57 | -0.28 | — | — | — | — | — | — | — | — | — | — | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (USD) | 342M | 350M | 366M | 353M | 376M | 789M | 676M | 623M | 438M | 383M |
| ↳ YoY growth | +23.0% | +2.5% | +4.4% | -3.6% | +6.6% | +109.8% | -14.4% | -7.7% | -29.8% | -12.6% |
| ↳ 5y CAGR | +18.5% | +19.7% | +19.9% | +13.6% | +6.2% | +18.2% | +14.0% | +11.3% | +4.4% | +0.3% |
| Borrowings, current (USD) | 3.75M | 0.00 | — | 0.00 | 4.69M | 0.00 | — | — | — | — |
| Lease liabilities (USD) | — | — | 115M | 105M | 92.8M | 24.7M | 17.5M | 45.6M | 41.9M | 36.1M |
| Cash and deposits (USD) | 10.6M | 15.1M | 13.9M | 83M | 29.2M | 181M | 64.5M | 32.9M | 10.6M | 34M |
| Intangible assets (USD) | 246M | 227M | 326M | 398M | 565M | 514M | 477M | 474M | 381M | 284M |
| Right-of-use assets (USD) | — | — | 99.5M | 89.9M | 77.7M | 27.8M | 16.3M | 34.5M | 32.1M | 27M |
| Net debt (borrowings + leases - cash) (USD) | -6.87M | -15.1M | — | 22.2M | 68.3M | -156M | — | — | — | — |
| Cash flow detail | ||||||||||
| Operating cash flow (USD) | 132M | 115M | 227M | 225M | 257M | 305M | 654M | 372M | 320M | 269M |
| Purchases of property, plant and equipment (USD) | -22M | -26.5M | -35.2M | -35.2M | -37.7M | -53.6M | -75.8M | -104M | -80.9M | -35.6M |
| Purchases of intangible assets (USD) | 0.00 | 0.00 | -1.18M | -1.24M | -1.4M | -90,000 | -5.09M | -1.7M | 0.00 | 0.00 |
| Change in receivables (cash effect) (USD) | -58.7M | -18.9M | -1.45M | 28.3M | -7.34M | -420M | 57.9M | 70M | 176M | 49.1M |
| Change in payables (cash effect) (USD) | 17.7M | -7.86M | 17.2M | 1.93M | 5.56M | 256M | 48.8M | -184M | -155M | -20.6M |
| Share buybacks (cash effect) (USD) | -13.3M | -20.2M | -67M | -18.7M | 0.00 | -2.69M | -577M | -425M | 0.00 | 0.00 |
| Interest paid (cash effect) (USD) | -8.06M | -17.9M | -21.3M | -23.7M | -22.7M | -38.1M | -37.5M | -48.1M | -61M | -45.1M |
| Income taxes paid (cash effect) (USD) | -73.4M | -73.7M | -30.6M | -37.7M | -46.3M | -106M | -214M | -78.3M | -28.2M | -7.85M |
| Share-based compensation (USD) | 11.4M | 10.2M | 10.8M | 16.2M | 20.5M | 25.2M | 30.1M | 18M | 23.3M | 30.7M |
| Operating cash flow before change in receivables (USD) | 191M | 134M | 228M | 197M | 264M | 725M | 596M | 302M | 144M | 220M |
| Free cash flow (OCF - PPE - intangibles) (USD) | 110M | 88.7M | 191M | 188M | 218M | 252M | 573M | 267M | 240M | 234M |
| Income detail | ||||||||||
| Total comprehensive income (USD) | 106M | 132M | 142M | 114M | 70.6M | 327M | 443M | 211M | -147M | -95.4M |
| Comprehensive income to owners (USD) | 106M | 132M | 142M | 114M | 70.6M | 327M | 443M | 211M | -147M | -95.4M |
| Provision for credit losses (USD) | 12M | 10.3M | 9.01M | 6.28M | 4.43M | 1.21M | 27.6M | 5.54M | 6.55M | 3.89M |
| Credit cost ratio (credit losses / average receivables) (%) | 3.9% | 3.0% | 2.5% | 1.7% | 1.2% | 0.2% | 3.8% | 0.9% | 1.2% | 0.9% |
| Reported | Feb 21, 2019 | Feb 21, 2019 | Feb 26, 2021 | Feb 26, 2021 | Feb 26, 2021 | Feb 24, 2022 | Feb 22, 2023 | Feb 22, 2024 | Feb 21, 2025 | Feb 20, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR. Press releases from the company's own website, newest first.
November 5, 2026
Quarterly revenue of $717 million and adjusted EBITDA of $94 million;
GAAP net income of $0.83/share and adjusted EPS of $1.16
DALLAS, Nov. 5, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2026 financial results. Financial highlights are as follows:

Dollars in millions, except per share amounts.
| | Q3 2026 | % Change Q3 2025 | YTD Sept. 30, 2026 | % Change YTD Sept. 30, 2025 |
| Revenue | $717.3 | 13 % | $2,768.9 | 40 % |
| Gross profit | $229.1 | 24 % | $803.8 | 39 % |
| Net income | $33.4 | 14 % | $116.7 | nm |
| GAAP diluted EPS | $0.83 | 9 % | $2.93 | nm |
| Adjusted diluted EPS* | $1.16 | 199 % | $4.01 | 252 % |
| Adjusted EBITDA* | $93.6 | 63 % | $333.1 | 85 % |
- See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "Non-GAAP Reconciliation Tables" for a reconciliation of non-GAAP items.
Business Highlights
-
Third quarter revenue and earnings exceeded guidance, driven by our travel nurse and allied businesses and a labor disruption reserve release.
-
Demand for travel nursing and allied strengthened further, and our strong execution drove volume up double digits over prior year and revenue growth for a third straight quarter.
-
Search revenue grew 15% year over year with strength across executive search and physician permanent placement.
-
Locum tenens results were on track with our expectations amid the business's ongoing process and technology transformation.
-
Our quarter-end cash balance was $256 million with a leverage ratio, calculated under the terms of our credit agreement, of 1.3x.
"We are encouraged by the continued growth in nursing and allied staffing. Demand strengthened during the third quarter and through October and our team is delivering for our clients through faster recruiting, automation, and around-the-clock execution. We also are making progress on improvements in our other segments," said Cary Grace, President and Chief Executive Officer of AMN Healthcare. "Healthcare organizations increasingly want better visibility and more strategic management of their total workforce. Our strategy to bring together our talent engagement, trusted client relationships, operational expertise, and technology-enabled solutions is well-timed with the marketplace's demands."
Third Quarter 2026 Results
Consolidated revenue for the quarter was $717 million, a 13% increase from the prior year and a 7% increase from the prior quarter. Net income was $33 million (4.7% of revenue), or $0.83 per diluted share, compared with net income of $29 million (4.6% of revenue), or $0.76 per diluted share in the third quarter of 2025. Adjusted diluted EPS in the third quarter was $1.16 compared with $0.39 in the same quarter a year ago.
Revenue for the Nurse and Allied Solutions segment was $460 million, higher by 27% year over year and up 9% from the prior quarter, driven by core nurse and allied businesses and labor disruption reserve releases from prior events we supported. Travel nurse staffing revenue was higher by 19% year over year and up 2% sequentially. Allied division revenue increased 11% year over year and was flat sequentially. Labor disruption contributed $59 million revenue in the quarter compared to $25 million in the prior quarter and $12 million in the year-ago quarter.
The Physician and Leadership Solutions segment reported revenue of $171 million, down 4% year over year and up 4% sequentially. Locum tenens revenue was $138 million, down 5% year over year and up 6% sequentially. Interim leadership revenue was down by 5% year over year and flat sequentially. Search revenue increased 15% year over year and was down 9% sequentially.
Technology and Workforce Solutions segment revenue was $86 million, a decrease of 9% year over year and 1% sequentially. Language services revenue was $69 million in the quarter, down 8% from the prior year and 1% sequentially. Vendor management systems revenue was $15 million, 11% lower year over year and flat from the prior quarter.
Consolidated gross margin was 31.9%, 280 basis points higher year over year and up 130 basis points sequentially. Higher margin in the Nurse and Allied Solutions segment, driven by the labor disruption reserve release, drove the sequential improvement.
Consolidated SG&A expenses were $149 million, or 20.8% of revenue, compared with $139 million, or 21.8% of revenue, in the same quarter last year. SG&A was $147 million, or 21.9% of revenue, in the previous quarter. The year-over-year increase in SG&A expenses was primarily due to liability insurance expense and the allowance for credit losses.
Income from operations was $51 million with an operating margin of 7.0%, compared with income of $48 million and 7.5%, respectively, in the same quarter last year. Adjusted EBITDA was $94 million, a year-over-year increase of 63%. Adjusted EBITDA margin was 13.0%, 390 basis points higher than the year-ago period.
At September 30, 2026, cash and cash equivalents totaled $256 million. Cash flow from operations was ($88 million) for the third quarter and $285 million year to date. The sequentially lower cash balance and negative operating cash flow resulted from refunding the majority of client deposits related to previous labor disruption events. Capital expenditures were $10 million in the third quarter, and we used $8.4 million to repurchase 250,685 shares at an average price of $33.50. The Company ended the quarter with total debt outstanding of $750 million with nothing drawn on our revolving credit facility.
Fourth Quarter 2026 Outlook
| Metric | Guidance* |
| Consolidated revenue | $655 - $670 million |
| Gross margin | 25.7% - 26.2% |
| SG&A as percentage of revenue | 21.2% - 21.7% |
| Operating margin | (0.1%) - 0.5% |
| Adjusted EBITDA margin | 5.8% - 6.3% |
*Note: Guidance percentage metrics are approximate. For a reconciliation of adjusted EBITDA margin, see the table entitled "Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin" below.
Revenue in the fourth quarter of 2026 is expected to be 10-12% lower than the prior year. This outlook assumes labor disruption revenue of $5 million this quarter compared with $124 million in Q4 2025. Nurse and Allied Solutions segment revenue is expected to be down 13-15% year over year, or up 13-15% excluding labor disruption. Physician and Leadership Solutions segment revenue is expected to be down 5-7% year over year. Technology and Workforce Solutions segment revenue is projected to be down 8-10% year over year.
Fourth quarter estimates for certain other financial items include depreciation of $12.5 million, depreciation in cost of revenue of $2.5 million, amortization expense of $15.5 million, share-based compensation expense of $6 million, integration and other expenses of $2 million, interest expense of $8.5 million, marginal adjusted tax rate of 28%, and 40.1 million diluted average shares outstanding.
Conference Call on November 5, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call to discuss its third quarter 2026 financial results and fourth quarter 2026 outlook on Thursday, November 5, 2026 at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://ir.amnhealthcare.com. Interested parties may participate live via telephone by registering at this link. Please follow the link and register with a valid e-mail address. After registering, the system will call you instantly and connect you into the conference call automatically.
Alternatively, you may dial in to the conference call by calling 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.
About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, direct hire and retained search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools, and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.
The Company's common stock is listed on the New York Stock Exchange under the symbol "AMN." For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication ("RSS") as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com.
Non-GAAP Measures
This earnings release and the non-GAAP reconciliation tables included with the earnings release contain certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company's condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, (3) adjusted net income, and (4) adjusted diluted EPS. The Company provides such non-GAAP financial measures because management believes that they are useful to both management and investors as a supplement, and not as a substitute, when evaluating the Company's operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin, and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions, allocating resources and for determining certain incentive compensation objectives. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly titled non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company's performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled "Non-GAAP Reconciliation Tables" under the caption entitled "Reconciliation of Non-GAAP Items" and the footnotes thereto or on the Company's website at https://ir.amnhealthcare.com/financials/quarterly-results. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company's website.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning future demand and supply for healthcare, contingent staffing and other services, client preferences, continued growth in the markets we serve, our ongoing process and technology transformations, our ability to advance our technology-enabled workforce solutions, the future results of our strategic initiatives, fourth quarter 2026 financial projections for consolidated and segment revenue, consolidated gross margin, operating margin, SG&A as a percent of revenue, adjusted EBITDA margin, labor disruption revenue, depreciation expense, depreciation in cost of revenue, share-based compensation expense, non-cash amortization expense, integration and other expenses, interest expense, adjusted tax rate, and number of diluted shares outstanding. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are also identified by words such as "believe," "project," "anticipate," "expect," "intend," "plan," "will," "may," "estimates," variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.
The targets and expectations noted in this release depend upon, among other factors, (i) the ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, artificial intelligence, online recruiting, internal travel agencies and float pools, telemedicine or otherwise and successfully hire and retain permanent staff, (ii) the duration and extent to which hospitals and other healthcare entities adjust their utilization of temporary nurses and allied healthcare professionals, physicians, healthcare leaders and other healthcare professionals and workforce technology applications as a result of the labor market or economic conditions, (iii) the magnitude and duration of the effects of any future pandemic or health crisis on demand and supply trends, our business, its financial condition and our results of operations, (iv) our ability to effectively address client demand by attracting and placing nurses and other clinicians, (v) our ability to recruit and retain sufficient quality healthcare professionals at reasonable costs, (vi) our ability to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs and requirements, including implementing changes that will make our services more tech-enabled and integrated, (vii) our ability to manage the pricing impact that the labor market or consolidation of healthcare delivery organizations may have on our business, (viii) the effects of economic downturns, inflation or slow recoveries, which could result in less demand for our services, increased client initiatives designed to contain costs, including reevaluating their approach as it pertains to contingent labor and managed services programs, other solutions and providers, pricing pressures and negatively impact payments terms and collectability of accounts receivable, (ix) our ability to develop and evolve our current technology offerings and capabilities and implement new infrastructure and technology systems to optimize our operating results and manage our business effectively, (x) our ability and the expense to comply with extensive and complex federal and state laws and regulations related to the conduct of our operations, costs and payment for services and payment for referrals as well as laws regarding employment practices, (xi) our ability to consummate and effectively incorporate acquisitions into our business, (xii) the negative effects that intermediary organizations may have on our ability to secure new and profitable contracts, (xiii) the extent to which the Great Resignation or a future pandemic or health crisis may disrupt our operations due to the unavailability of our employees or healthcare professionals due to burnout, illness, risk of illness, quarantines, travel restrictions, mandatory vaccination requirements, or other factors that limit our existing or potential workforce and pool of candidates, (xiv) security breaches and cybersecurity incidents, including ransomware, that could compromise our information and systems, which could adversely affect our business operations and reputation and could subject us to substantial liabilities (xv) the severity and duration of the impact the labor market, economic downturn or any future pandemic or health crisis has on the financial condition and cash flow of many hospitals and healthcare systems such that it impairs their ability to make payments to us, timely or otherwise, for services rendered and (xvi) any increase to our business and operating risks as we develop new services and clients, further adopt and integrate artificial intelligence into our services and operations, enter new lines of business and focus more of our business on providing a full range of client solutions.
For a discussion of additional risk factors and a more complete discussion of some of the cautionary statements noted above that could cause actual results to differ from those implied by the forward-looking statements contained in this press release, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2025. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.
October 19, 2026
Average physician signing bonus jumps 29% to nearly $50,000 as competition for specialists intensifies
DALLAS, Oct. 19, 2026 /PRNewswire
/ -- Gastroenterologists are now offered the highest average starting salary of any physician, at $654,000, according to AMN Healthcare's annual review of physician recruiting incentives. They displace orthopedic surgeons, who had topped the list in each of the previous four years and whose average starting salary fell 12% year over year, to $507,000.

The 2026 Review of Physician and Advanced Practitioner Recruiting Incentives
, now in its 33rd year, tracks the starting salaries and other incentives that hospitals, medical groups and other facilities offer to physicians and advanced practice professionals. The report finds that the average starting salary for all physicians is $419,000, up from $403,000 last year.
Signing bonuses are also climbing sharply with the average signing bonus offered to physicians reaching $49,306, up 29% from $38,215 last year. Signing bonuses were offered in 87% of the search engagements AMN Healthcare conducted, up from 74% the prior year.
"An aging population is driving demand for specialists faster than the supply of physicians in procedural fields like gastroenterology, cardiology and urology can keep up," said Robin Johnson, Group President of Nursing, Allied & Physician Solutions at AMN Healthcare. "Hospitals and medical groups are responding by competing harder for every candidate and signing bonuses have become one of the most effective ways to stand out when a physician is weighing multiple offers."
**Specialists Command the Top Salaries
**Specialists account for every position in the top 10 of the report's starting salaries. After gastroenterology, the highest average starting salaries are:
-
Interventional cardiology at $650,000
-
Urology at $638,000
-
Otolaryngology at $575,000
-
Radiology at $571,000
-
Non-invasive cardiology at $568,000
Urologists saw the largest year-over-year gain, a 22.5% increase. Non-invasive cardiologists followed with 20.9%, and gastroenterologists with 18.5%.
Primary care physicians continue to be offered far less. Family medicine physicians are offered an average of $291,000, a 5.8% increase. Internal medicine physicians are offered $289,000, down 1.2%. Pediatricians are at the low end of the scale at $231,000, down 10.6%.
Specialists made up 84% of the physician searches AMN Healthcare conducted, compared with 16% for primary care.
**Academic Positions Pay Less
**Practice setting significantly affects pay. Physicians in academic positions are offered an average starting salary of $362,000, compared with $452,000 for non-academic positions. Academic medical centers accounted for 30% of AMN Healthcare's search engagements, and 90% of those were for clinical faculty. That is the highest share in the report's history.
**NPs Remain Most Requested for Sixth Straight Year
**Nurse practitioners were again AMN Healthcare's most requested search engagement; the sixth consecutive year they have led the list. NP starting salaries held steady at an average of $180,000.
"Organizations increasingly see nurse practitioners as a core part of their workforce strategy, not a stopgap. NPs are expanding access in primary care, supporting specialty practices and meeting rising demand for behavioral health and telehealth services," Johnson said.
**Contract Structures Shifting
**Most contracts (68%) offered a salary plus a production bonus. Bonuses were most often tied to RVUs (relative value units), which measure the volume and complexity of the services a physician provides. The report also notes a growing shift among physicians toward 1099 independent contractor arrangements. It also finds that telehealth has become a permanent practice setting.
The full report is available at: https://online.flippingbook.com/view/1007051548/
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding AMN Healthcare Services Inc
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| HYP | 2.86% | 60,997 | $ 1.974M | Jun 30, 2026 |
| TCV | 2.25% | 117,166 | $ 4.46M | Nov 18, 2026 |
| ALIL | 2.04% | 11,003 | $ 420K | Nov 18, 2026 |
| CPAI | 1.93% | 219,717 | $ 7.112M | Jun 30, 2026 |
| SIXS | 1.32% | 51,217 | $ 1.917M | Nov 12, 2026 |
| CGV | 1.27% | 48,738 | $ 1.639M | Jul 31, 2026 |
| VAMO | 0.94% | 30,219 | $ 1.016M | Jul 31, 2026 |
| DSMC | 0.67% | 26,885 | $ 870.267K | Jun 30, 2026 |
| SMIZ | 0.57% | 45,540 | $ 1.561M | Aug 31, 2026 |
| WCEO | 0.49% | 1,448 | $ 48.696K | Jul 31, 2026 |
| LITL | 0.44% | 654 | $ 24.917K | Nov 17, 2026 |
| SYZ | 0.40% | 8,419 | $ 272.523K | Jun 30, 2026 |
| EHLS | 0.37% | 4,986 | $ 197.645K | Nov 17, 2026 |
| SQLV | 0.36% | 3,215 | $ 104.07K | Jun 30, 2026 |
| COPY | 0.35% | 42,744 | $ 1.465M | Aug 31, 2026 |
| BSVO | 0.32% | 200,295 | $ 7.63M | Nov 18, 2026 |
| RUSC | 0.29% | 7,156 | $ 231.64K | Jun 30, 2026 |
| FSCC | 0.18% | 19,015 | $ 651.834K | Aug 31, 2026 |
| VFQY | 0.18% | 26,449 | $ 906.672K | Aug 31, 2026 |
| VFMF | 0.17% | 49,317 | $ 1.691M | Aug 31, 2026 |
| IVSS | 0.13% | 1,092 | $ 35.348K | Jun 30, 2026 |
| AVSC | 0.12% | 94,439 | $ 3.744M | Nov 16, 2026 |
| PSC | 0.11% | 79,212 | $ 2.564M | Jun 30, 2026 |
| VFVA | 0.10% | 27,535 | $ 943.9K | Aug 31, 2026 |
| VFMO | 0.07% | 38,901 | $ 1.334M | Aug 31, 2026 |
| RESM | 0.06% | 66 | $ 2,136.42 | Jun 30, 2026 |
| SMDX | 0.05% | 1,692 | $ 67.071K | Nov 17, 2026 |
| DFAT | 0.04% | 368,726 | $ 13.798M | Nov 12, 2026 |
| DFSV | 0.04% | 273,545 | $ 10.236M | Nov 12, 2026 |
| DFAS | 0.03% | 273,036 | $ 10.217M | Nov 12, 2026 |
| EBI | 0.02% | 4,327 | $ 148.33K | Aug 31, 2026 |
| SFGV | 0.02% | 6,622 | $ 250K | Nov 18, 2026 |
| DXUV | 0.02% | 25,119 | $ 939.953K | Nov 12, 2026 |
| MSSM | 0.01% | 2,559 | $ 87.723K | Aug 31, 2026 |
| DFSU | 0.01% | 6,955 | $ 260.256K | Nov 12, 2026 |
| DFAC | 0.01% | 161,202 | $ 6.032M | Nov 12, 2026 |
| DCOR | 0.00% | 53,265 | $ 1.993M | Nov 12, 2026 |
| DFAU | 0.00% | 10,088 | $ 377.493K | Nov 12, 2026 |
| DFUS | 0.00% | 12,323 | $ 461.127K | Nov 12, 2026 |
| DFUV | 0.00% | 1,803 | $ 67.468K | Nov 12, 2026 |
| AVUS | 0.00% | 8,655 | $ 343.084K | Nov 16, 2026 |
| AVSU | 0.00% | 297 | $ 11.773K | Nov 16, 2026 |


